Docetaxel Injection, Solution, Concentrate
Product Images NDC 45963-765

This text is showing a survival probability chart with two groups, TPF (n=255) and PF (n=268). The x-axis shows survival time in months, and the y-axis shows the probability of survival. The chart displays survival probability of both groups at different intervals of time. The number of patients at risk is also displayed for both groups at different intervals of time.*

This appears to be a set of instructions for patients regarding the use of Docetaxel Injection for the treatment of different types of cancers including stomach, head and neck, breast, non-small cell lung, and prostate cancer. It emphasizes the importance of taking oral corticosteroid medicine as directed by the healthcare provider, and provides a dosing schedule for the medicine. The text specifies different treatment days and times for each cancer type, suggesting that the dosage and frequency may vary depending on the condition being treated.*

This is a medication called Docetaxel, available in a solution that can be injected intravenously. Each mL of the solution contains 20 mg of Docetaxel along with other substances like polysorbate 80, povidone, and ethanol. The medication is manufactured in Romania by Sindan Pharma SRL and is distributed in the USA by Actavis Pharma. The solution is meant to be added directly to the infusion solution and should only be handled and administered by a healthcare professional. Complete information about dosage and administration can be found in the package insert.*

This is a product description for Docetaxel, a cytotoxic agent that is administered via intravenous infusion, manufactured by Sindan Pharma SRL in Romania and distributed by Actavis Pharma in the United States. The product comes in a single-dose vial containing 80mg/4mL of the drug and has a vial stopper made without natural rubber latex to minimize allergic reactions. The dosage administration instructions are given in the package insert. The product should be stored at room temperature, with excursions permitted to 15-30°C, and protected from light. It contains polysorbate 80 and ethanol along with docetaxel, USP, povidone, and dtric acid anhydrous. No varnish, lot/exp or serialization coding area is needed.*

This text is describing a medication called Docetaxel Injection USP in a single-dose vial containing 160mg/8mL of the medication (20mg/mL). It is intended for intravenous infusion only as it is a cytotoxic agent. The package includes instructions for dosage and administration, and medication should be kept out of reach of children. The medication is sterile, nonpyrogenic, and preservative-free. The vial stopper is not made with natural rubber latex. The medication is made in Italy and distributed by Actavis Pharma Inc. in the USA. It is stored at temperatures of 25°C (77°F), with excursions permitted at 15° to 30°C (59 to 86°F), protected from light, and any unused contents should be discarded appropriately.*

This appears to be a graph with the heading "DFS Probability (%)" and a scale on the x-axis marked with numbers 18, 24, 42, 48, 54, 60, and 6. The y-axis is not visible in the text provided. The graph likely shows the probability of disease-free survival over time (in months) for a certain group or population.*

The text indicates a graph with the title "Cumulative Probability" and a line graph with the title "Overall Survival". The graph shows survival time in months on the X-axis and the probability of survival on the Y-axis. A Log-rank p-value of 0.010 was obtained.*

This is a graph showing the cumulative probability of survival over time in months, as indicated on the x-axis. The y-axis shows the probability of survival. The graph also includes a Logerank score and an "Overall Survival" label.*

This appears to be a graph showing survival probability over time in months. The x-axis represents survival time, while the y-axis represents survival probability. Unfortunately, there is not enough information to determine what the data refers to or what the units are.*